The Journal of urology · 2025
Perioperative Antimicrobial Strategies in Inflatable Penile Prosthesis Surgery: Associations Between Antifungals, Oral Antibiotics, and Intravenous Antibiotic Duration, and Infection Outcomes.
СтатьяМногоцентровое исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Abou Chawareb Elia, Hammad Muhammed A M, Azad Babak, Gross Martin S, Payne Brayden, Swerdloff Daniel, Miller Jake A, Andrianne Robert, Burnett Arthur L, Gross Kelli, Hatzichristodoulou Georgios, Hotaling James M, Hsieh Tung-Chin, Jones James M, Lentz Aaron, Modgil Vaibhav, Osmonov Daniar, Park Sung Hun, Pearce Ian, Perito Paul, Sadeghi-Nejad Hossein, Sempels Maxime, Suarez-Sarmiento Alfredo, Simhan Jay, van Renterghem Koenraad, Warner J Nicholas, Ziegelmann Matthew, Yafi Faysal A, Barham David W
Аннотация
PURPOSE: This study aims to evaluate the association between antimicrobial practices, including oral antibiotics, IV antibiotics, and antifungal prophylaxis, and infection outcomes in patients undergoing primary or revision inflatable penile prosthesis surgery.
MATERIALS AND METHODS: We conducted a multicenter, retrospective cohort study of 5261 patients who underwent primary or revision inflatable penile prosthesis surgery at 16 specialized centers across the United States, Europe, and Korea from July 2016 to July 2021. Patient data included demographic and clinical characteristics, antibiotic and antifungal administration, and infection outcomes. The primary outcome was infection after inflatable penile prosthesis placement. Univariable and multivariable regression analyses were performed to identify predictors of infection.
RESULTS: The overall infection rate was 1.9% (n = 102), with higher rates among diabetic patients (P = .023), those with prior inflatable penile prosthesis infection (P < .001), or undergoing revision surgery (P < .001). Multivariable analysis identified diabetes (odds ratio [OR] = 1.68, P = .022) and previous inflatable penile prosthesis infection (OR = 4.67, P < .001) as independent risk factors for infection. Perioperative IV antifungal use was significantly associated with a lower infection risk (OR = 0.22, P < .001), whereas postoperative oral antibiotics (P = .5) and prolonged IV antibiotic prophylaxis (>24 hours; P = .2) did not demonstrate protective effects. Preoperative and postoperative oral antibiotics were not associated with a statistically significant reduction in infection after adjustment for confounding variables.
CONCLUSIONS: This large multicenter study highlights a significant association between perioperative antifungal prophylaxis and lower infection risk in inflatable penile prosthesis surgery while demonstrating the limited utility of preoperative and postoperative oral antibiotics and prolonged IV prophylaxis. These findings support evidence-based antimicrobial stewardship to optimize outcomes and minimize complications, including antibiotic resistance.
MATERIALS AND METHODS: We conducted a multicenter, retrospective cohort study of 5261 patients who underwent primary or revision inflatable penile prosthesis surgery at 16 specialized centers across the United States, Europe, and Korea from July 2016 to July 2021. Patient data included demographic and clinical characteristics, antibiotic and antifungal administration, and infection outcomes. The primary outcome was infection after inflatable penile prosthesis placement. Univariable and multivariable regression analyses were performed to identify predictors of infection.
RESULTS: The overall infection rate was 1.9% (n = 102), with higher rates among diabetic patients (P = .023), those with prior inflatable penile prosthesis infection (P < .001), or undergoing revision surgery (P < .001). Multivariable analysis identified diabetes (odds ratio [OR] = 1.68, P = .022) and previous inflatable penile prosthesis infection (OR = 4.67, P < .001) as independent risk factors for infection. Perioperative IV antifungal use was significantly associated with a lower infection risk (OR = 0.22, P < .001), whereas postoperative oral antibiotics (P = .5) and prolonged IV antibiotic prophylaxis (>24 hours; P = .2) did not demonstrate protective effects. Preoperative and postoperative oral antibiotics were not associated with a statistically significant reduction in infection after adjustment for confounding variables.
CONCLUSIONS: This large multicenter study highlights a significant association between perioperative antifungal prophylaxis and lower infection risk in inflatable penile prosthesis surgery while demonstrating the limited utility of preoperative and postoperative oral antibiotics and prolonged IV prophylaxis. These findings support evidence-based antimicrobial stewardship to optimize outcomes and minimize complications, including antibiotic resistance.